MLAB
Mesa Laboratories·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 2
Bearish signal 1
High Gross Profit Margin
Significant Net Income Decline
EPS Beats Expectation
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About MLAB
Mesa Laboratories, Inc.
A global leader in the design and manufacturing of life science tools and critical quality control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries
Healthcare Equipment and Supplies
03/26/1982
03/02/1984
NASDAQ Stock Exchange
730
03-31
Common stock
12100 West Sixth Avenue, Lakewood, Colorado 80228
--
Mesa Laboratories, Inc., was incorporated under the laws of the State of Colorado on March 26, 1982. The company pursues a strategy of focusing on quality control products that are driven by regulation and exported to niche markets. The company is more inclined to a market with limited competition, where it can establish authority and achieve high gross profit margins. The company has two divisions, based in four different locations. The company's instrument division mainly designs, produces and sells quality control instruments and disposable products related to the healthcare, pharmaceutical, food and beverage, medical equipment, industrial hygiene, semiconductor and petrochemical industries. The company's biological indicators division is mainly engaged in the manufacture and promotion of biological indicators and distributive chemical indicators used to evaluate the effectiveness of sterilization processes, including steam, gas, hydrogen peroxide and radiation in the hospital, dental, medical device and pharmaceutical industries.
Company Financials
EPS
MLAB has released its 2026 Q2 earnings. EPS was reported at 2.75, versus the expected 1.56, beating expectations. The chart below visualizes how MLAB has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
MLAB has released its 2026 Q2 earnings report, with revenue of 60.74M, reflecting a YoY change of 5.02%, and net profit of 2.48M, showing a YoY change of -27.77%. The Sankey diagram below clearly presents MLAB's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
